Healthy volunteer study of a new injection (phase 1)
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Weigh at least 110 pounds (women) or 125 pounds (men), with a normal body mass index (18-30)
- Be generally healthy, with no major medical conditions
- Agree to use effective birth control (if you can have children) for the study and 3 months after
- Not have allergies to the drug ingredients, and have no cancer or serious infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called GenSci155 in healthy adults to see if it is safe and how the body handles it. It is a first-in-human trial, so participants will be closely monitored.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
This is an early study testing a new medicine called CIT-013. It is given as an injection under the skin, and the goal is to see if it is safe and how the body handles it. It is for healthy volunteers.
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
Hear when a new Healthy Adult Trial Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.